Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLG | P54098 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 3/20 | 0.54 |
| ▸ | P2RY2 | P41231 | 5/20 | 0.53 |
| ▸ | P2RY4 | P51582 | 3/20 | 0.53 |
| ▸ | P2RY6 | Q15077 | 3/20 | 0.53 |
| ▸ | DTYMK | P23919 | 2/20 | 0.47 |
| ▸ | NT5E | P21589 | 1/20 | 0.45 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL416602 | 1.00 | POLG (0.55) | POLGPOLBP2RY2P2RY4P2RY6 | |
| SCHEMBL15810673 | 1.00 | POLG (0.55) | POLGPOLBP2RY2P2RY4P2RY6 | |
| SCHEMBL3470530 | 0.90 | POLB (0.55) | POLB | |
| SCHEMBL20906735 | 0.90 | POLG (0.56) | POLGPOLBP2RY2P2RY4P2RY6 | |
| SCHEMBL2981336 | 0.90 | POLG (0.56) | POLGPOLBP2RY2P2RY4P2RY6 | |
| SCHEMBL2981333 | 0.90 | POLG (0.56) | POLGPOLBP2RY2P2RY4P2RY6 | |
| SCHEMBL25492503 | 0.89 | POLG (0.70) | POLGPOLBP2RY2P2RY4P2RY6 | |
| SCHEMBL20906738 | 0.89 | POLG (0.55) | POLGPOLBP2RY2P2RY4P2RY6 | |
| SCHEMBL20906736 | 0.89 | POLG (0.55) | POLGPOLBP2RY2P2RY4P2RY6 | |
| SCHEMBL8409011 | 0.89 | POLG (0.70) | POLGPOLBP2RY2P2RY4P2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1017 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250320485-A1 | METHODS AND COMPOSITIONS FOR DETECTING GENOMIC METHYLATION | ILLUMINA INC (US) | 2025-10-16 | — | — | US | claimed |
| US-20250210148-A1 | METHOD OF PRODUCING DATA-ENCODED NUCLEIC ACID AND NUCLEIC ACID PRODUCED BY THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-06-26 | — | — | US | claimed |
| US-20250051840-A1 | DETECTION OF GENETIC AND EPIGENETIC INFORMATION IN A SINGLE WORKFLOW | FOUNDATION MEDICINE, INC. (US) | 2025-02-13 | — | — | US | claimed |
| EP-4481057-A1 | SAMPLE PREPARATION METHODS USING MODIFIED BASES FOR RAPID IDENTIFICATION AND SEQUENCING | Depixus (FR) | 2024-12-25 | — | — | EP | claimed |
| EP-4457357-A2 | DETECTION OF GENETIC AND EPIGENETIC INFORMATION IN A SINGLE WORKFLOW | Foundation Medicine, Inc. (US) | 2024-11-06 | — | — | EP | claimed |
| CN-118541493-A | Detection of genetic and epigenetic information in a single workflow | 基金会医学公司 | 2024-08-23 | — | — | CN | claimed |
| EP-4392555-A2 | METHODS AND COMPOSITIONS FOR DETECTING GENOMIC METHYLATION | Illumina, Inc. (US) | 2024-07-03 | — | — | EP | claimed |
| WO-2023129965-A2 | DETECTION OF GENETIC AND EPIGENETIC INFORMATION IN A SINGLE WORKFLOW | FOUNDATION MEDICINE, INC. (US) | 2023-07-06 | — | — | WO | claimed |
| WO-2023028478-A2 | METHODS AND COMPOSITIONS FOR DETECTING GENOMIC METHYLATION | ILLUMINA, INC. (US) | 2023-03-02 | — | — | WO | claimed |
| US-10799602-B2 | Method for increasing expression of RNA-encoded proteins | CUREVAC AG (DE) | 2020-10-13 | — | — | US | claimed |
| US-10293060-B2 | Method for increasing expression of RNA-encoded proteins | CUREVAC AG (DE) | 2019-05-21 | — | — | US | claimed |
| US-20190100784-A1 | RNA ANALYSIS BY TOTAL HYDROLYSIS | CureVac SE (DE) | 2019-04-04 | — | — | US | claimed |
| EP-3423595-A1 | RNA ANALYSIS BY TOTAL HYDROLYSIS | CureVac AG (DE) | 2019-01-09 | — | — | EP | claimed |
| US-20030039976-A1 | Methods for base counting | PE CORPORATION (NY) | 2003-02-27 | — | — | US | claimed |
| EP-4747380-A1 | MODULATING EXPRESSION OF ALAS1 (5'-AMINOLEVULINATE SYNTHASE 1) GENE | CRISPR Therapeutics AG (CH) | 2026-05-27 | — | — | EP | disclosed |
| WO-2026103936-A1 | CHEMICALLY MODIFIED CIRCULAR RNA MOLECULE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 上海元码智药生物技术有限公司 | 2026-05-21 | — | — | WO | disclosed |
| US-20260137769-A1 | NUCLEIC ACID MOLECULES AND USES THEREOF | CureVac SE (DE) | 2026-05-21 | — | — | US | disclosed |
| WO-2005094421-A2 | METHODS FOR CONCURRENT IDENTIFICATION AND QUANTIFICATION OF AN UNKNOWN BIOAGENT | ISIS PHARMACEUTICALS, INC. (US) | 2005-10-13 | — | — | WO | disclosed |
| WO-2005089128-A2 | RAPID IDENTIFICATION OF MICROBIAL AGENTS | ISIS PHARMACEUTICALS, INC. (US) | 2005-09-29 | — | — | WO | disclosed |
| US-20030039976-A1 | Methods for base counting | PE CORPORATION (NY) | 2003-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10293060-B2 | Method for increasing expression of RNA-encoded proteins | STING1, UPF1, CUTA | POLG 397/4885POLB 273/4885P2RY2 4010/4885 |
| US-10799602-B2 | Method for increasing expression of RNA-encoded proteins | STING1, UPF1, CUTA | POLG 397/4885POLB 273/4885P2RY2 4010/4885 |
| US-20260137769-A1 | NUCLEIC ACID MOLECULES AND USES THEREOF | RNMT, RNGTT, NSUN3 | POLG 1112/4885POLB 733/4885P2RY2 356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.